Bolt Biotherapeutics
BOLT
BOLT
72 hedge funds and large institutions have $449M invested in Bolt Biotherapeutics in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 29 increasing their positions, 11 reducing their positions, and 7 closing their positions.
Holders
72
Holders Change
+11
Holders Change %
+18.03%
% of All Funds
1.26%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
19
Increased
29
Reduced
11
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
SC
1
Samlyn Capital
New York
|
$9.38M |
2 |
2
BlackRock
New York
|
$18.4M |
3 |
SCM
3
Suvretta Capital Management
New York
|
$16.8M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$12.6M |
5 |
PAMS
5
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
$2.35M |